value-based care

Engaging Payers

Partnership in Value-Based Care: Becoming and Finding Good Teammates

05/19/2020

Lili Brillstein, MPH—Column Editor

Value-based care is a whole-person philosophy that relies on the diverse expertise of various stakeholders and the ability of each and all to effectively collaborate to deliver the most effective and comprehensive...

...

05/19/2020

Journal of Clinical Pathways

Perspectives

The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study

03/16/2020

Andrew Hertler, MD, FACP

William A Flood, MD, MS

Ray Page, DO, PhD, FACOI, FASCO

Barry Brooks, MD

Steve L D’Amato, BSPharm, BCOP

Michael Kolodziej, MD

Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...

...

03/16/2020

Journal of Clinical Pathways

Research Reports

The Oncology Care Model Performance Period 2 Results: Practices Are Making Some Progress, But Major Challenges Remain

12/13/2018

Charles Saunders, MD

Abstract: When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly...

...

12/13/2018

Journal of Clinical Pathways

Pathways in Focus

Applying First Principles Thinking to Cancer Care Delivery

08/16/2017

Aymen Elfiky, MD, MSc, MBA—Column Editor

A first principle is a basic, foundational, self-evident proposition or assumption that cannot be deduced from any other proposition or assumption. The concept of first principles thinking has been advocated by...

A...

08/16/2017

Journal of Clinical Pathways

Interview

Clinical Pathways and Value-Based Care at the Dana Farber Cancer Institute

08/03/2017

JCP Editors

Journal of Clinical Pathways spoke with Aymen Elfiky, MD, MPH, MSc, attending physician, clinical oncology, Dana Farber Cancer Institute (Boston, MA), about clinical pathway implementation at the Institute,...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Benefits and Shortcomings of Oncology Value Frameworks for Payers

08/03/2017

JCP Editors

Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Multidisciplinary Quality Measures Identified for Head and Neck Cancer

07/24/2017

JCP Editors

Researchers have identified five quality metrics to help improve head and neck cancer care, published in Cancer (online July 20, 2017; doi:10.1002/cncr.30902). ----- Related Content Quality Measures for NSCLC...

...

07/24/2017

Journal of Clinical Pathways

Research in Review

Clinical Trials Improve Survival, Lower Costs for Patients With Cancer

06/27/2017

JCP Editors

Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...

...

06/27/2017

Journal of Clinical Pathways

Interview

The Shaping of Clinical Pathways Through User-Defined Value-Based Care

03/27/2017

JCP Editors

Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning...

...

03/27/2017

Journal of Clinical Pathways

Research in Review

Treatment Advances for Advanced-Stage NSCLC Have Increased Survival

01/05/2017

JCP Editors

Shifts in treatments of advanced-stage non-small cell lung cancer (NSCLC) have resulted in survival and spending gains over time, according to a report published in the Journal of Clinical Oncology. ----- Related...

Shifts...

01/05/2017

Journal of Clinical Pathways